Johnson & Johnson – Artificial intelligence is helping revolutionize healthcare as we know it
Back
In a time when chronic diseases are on the rise and people are living longer than ever before, novel solutions for better patient care are urgently needed. In healthcare’s next chapter, a new type of technology will play a bigger role than ever before.
Enter artificial intelligence, or AI. Rooted in the simulation of human intelligence by computer systems and machines, AI has the potential to transform how humans learn, work, and interact with one another in every aspect of life.
The promise that AI holds is why Johnson & Johnson is actively using the technology in different ways, from speeding up the process of discovering new medicines to helping surgeons analyze the results of procedures. In the operating room (OR), for example, surgical video is frequently taken during procedures to provide education, research methodologies, and quality improvement strategies to medical professionals.
Johnson & Johnson MedTech is evolving a portfolio of digital solutions for the OR that use AI algorithms to essentially “cut a highlight reel of these videos” in a matter of minutes, explained Shan Jegatheeswaran, Global Head of MedTech Digital, Johnson & Johnson, so surgeons can re-watch significant events from their procedures. Without AI, this process could take hours—even days—to complete. Now, surgeons can look at what happened during procedures practically in real time and share the video with residents and peers, offering valuable post-case analysis and learning opportunities.
Medical devices, including connected devices, robotic platforms and digital solutions are also evolving with AI to enhance their capabilities. Johnson & Johnson MedTech’s Monarch™ Platform for bronchoscopy, for example, lets physicians examine areas of the lung that are more difficult to access with conventional bronchoscopes—and that can aid in earlier lung cancer diagnosis. The flexible robotics system uses preoperative CT scans of the lungs to inform the procedure, but tracking objects in such a dynamic environment in real time can be complex. The Monarch R&D team uses AI and machine learning (ML) algorithms to develop and refine the Monarch Platform’s navigation, which helps physicians guide the bronchoscope during lung biopsy procedures and allows them to locate a potential tumor more accurately. This leads to more accurate diagnosis and treatment.
Read the full article here.
Submitted by Johnson & Johnson